Abraham Bayer

686 total citations
18 papers, 366 citations indexed

About

Abraham Bayer is a scholar working on Immunology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Abraham Bayer has authored 18 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Abraham Bayer's work include Cardiac Fibrosis and Remodeling (5 papers), interferon and immune responses (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Abraham Bayer is often cited by papers focused on Cardiac Fibrosis and Remodeling (5 papers), interferon and immune responses (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Abraham Bayer collaborates with scholars based in United States, Russia and India. Abraham Bayer's co-authors include Pilar Alcaide, Jodie L. Babitt, Susanna Canali, Chia‐Yu Wang, Kimberly B. Zumbrennen‐Bullough, Som Dev, Kuljeet Kaur, Yang Xu, Xia Xiao and Sasha Smolgovsky and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Abraham Bayer

16 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abraham Bayer United States 9 151 136 101 99 89 18 366
J. Nico P. de Villiers South Africa 11 135 0.9× 114 0.8× 90 0.9× 108 1.1× 33 0.4× 20 373
Eva M. Muchitsch Austria 13 298 2.0× 127 0.9× 101 1.0× 30 0.3× 81 0.9× 23 466
Noémi Roy United Kingdom 12 147 1.0× 131 1.0× 119 1.2× 29 0.3× 85 1.0× 26 419
H Gaitantzi Germany 10 86 0.6× 82 0.6× 148 1.5× 57 0.6× 33 0.4× 16 420
Jens Posma Netherlands 6 129 0.9× 41 0.3× 68 0.7× 8 0.1× 35 0.4× 15 299
Chittibabu Vatte Saudi Arabia 11 40 0.3× 47 0.3× 85 0.8× 10 0.1× 21 0.2× 38 274
Ryoko Shiga Japan 7 35 0.2× 21 0.2× 122 1.2× 30 0.3× 62 0.7× 10 382
Kathrin Schwierczek Germany 4 134 0.9× 30 0.2× 63 0.6× 5 0.1× 91 1.0× 5 345
Caen Jp France 11 185 1.2× 71 0.5× 55 0.5× 14 0.1× 25 0.3× 44 343
Dorothée Thuillier France 8 54 0.4× 37 0.3× 110 1.1× 12 0.1× 19 0.2× 8 394

Countries citing papers authored by Abraham Bayer

Since Specialization
Citations

This map shows the geographic impact of Abraham Bayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Bayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Bayer more than expected).

Fields of papers citing papers by Abraham Bayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abraham Bayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Bayer. The network helps show where Abraham Bayer may publish in the future.

Co-authorship network of co-authors of Abraham Bayer

This figure shows the co-authorship network connecting the top 25 collaborators of Abraham Bayer. A scholar is included among the top collaborators of Abraham Bayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abraham Bayer. Abraham Bayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sun, Yin, Abraham Bayer, Daniel Lee, et al.. (2025). Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis. Circulation Research. 136(5). 473–490. 3 indexed citations
2.
Bayer, Abraham, Zoie Magri, Hayley I. Muendlein, Alexander Poltorak, & Pilar Alcaide. (2025). MyD88 determines T cell fate through BCAP-PI3K signaling. The Journal of Immunology. 214(3). 433–445. 1 indexed citations
3.
Smolgovsky, Sasha, Abraham Bayer, Eric Reed, et al.. (2025). Microglial STING is a central safeguard against neurological decline with age. Cell Reports. 44(6). 115749–115749.
4.
Smolgovsky, Sasha, Abraham Bayer, Mark Aronovitz, et al.. (2025). Experimental pressure overload induces a cardiac neoantigen specific humoral immune response. Journal of Molecular and Cellular Cardiology. 201. 87–93. 1 indexed citations
6.
Bayer, Abraham, et al.. (2024). Deletion of MyD88 in T Cells Improves Antitumor Activity in Melanoma. American Journal Of Pathology. 194(6). 1007–1019. 2 indexed citations
7.
Bayer, Abraham, et al.. (2024). A Modular Turn‐On Strategy to Profile E2‐Specific Ubiquitination Events in Living Cells. Angewandte Chemie International Edition. 63(13). e202319579–e202319579. 1 indexed citations
8.
Bayer, Abraham, Sasha Smolgovsky, Kuljeet Kaur, et al.. (2024). Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction. Nature Cardiovascular Research. 3(8). 970–986. 11 indexed citations
9.
Bayer, Abraham, et al.. (2023). AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis. Cancers. 15(20). 4958–4958. 5 indexed citations
10.
Smolgovsky, Sasha, Abraham Bayer, Kuljeet Kaur, et al.. (2023). Impaired T cell IRE1α/XBP1 signaling directs inflammation in experimental heart failure with preserved ejection fraction. Journal of Clinical Investigation. 133(24). 24 indexed citations
11.
Bayer, Abraham, Sasha Smolgovsky, Njabulo Ngwenyama, et al.. (2023). T-Cell MyD88 Is a Novel Regulator of Cardiac Fibrosis Through Modulation of T-Cell Activation. Circulation Research. 133(5). 412–429. 23 indexed citations
12.
Bayer, Abraham, et al.. (2022). AKT1 Is Required for a Complete Palbociclib-Induced Senescence Phenotype in BRAF-V600E-Driven Human Melanoma. Cancers. 14(3). 572–572. 8 indexed citations
13.
Bayer, Abraham & Pilar Alcaide. (2021). MyD88: At the heart of inflammatory signaling and cardiovascular disease. Journal of Molecular and Cellular Cardiology. 161. 75–85. 58 indexed citations
14.
Newton, Gail, Kuljeet Kaur, Francisco J. Carrillo‐Salinas, et al.. (2021). Endothelial STING controls Tcell transmigration in an IFN-I dependent manner. JCI Insight. 6(15). 38 indexed citations
15.
16.
Wang, Chia‐Yu, Xia Xiao, Abraham Bayer, et al.. (2019). Ablation of Hepatocyte Smad1, Smad5, and Smad8 Causes Severe Tissue Iron Loading and Liver Fibrosis in Mice. Hepatology. 70(6). 1986–2002. 34 indexed citations
17.
Wang, Chia‐Yu, et al.. (2018). Iron, erythropoietin, and inflammation regulate hepcidin in Bmp2‐deficient mice, but serum iron fails to induce hepcidin in Bmp6‐deficient mice. American Journal of Hematology. 94(2). 240–248. 28 indexed citations
18.
Canali, Susanna, Chia‐Yu Wang, Kimberly B. Zumbrennen‐Bullough, Abraham Bayer, & Jodie L. Babitt. (2017). Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6. American Journal of Hematology. 92(11). 1204–1213. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026